Revvity wins $37.8M contract to screen UK newborns for rare diseases
Diagnostics company Revvity will sequence the DNA of newborns to help identify rare genetic conditions as part of Genomic England's efforts to bolster early disease detection. Last year, Genomics England launched a study to screen ...
Diagnostics company Revvity will sequence the DNA of newborns to help identify rare genetic conditions as part of Genomic England's efforts to bolster early disease detection.
Last year, Genomics England launched a study to screen ...
